Droplet printable microfluidic arrays for high-throughput screening of 3D cell c...
Droplet printable microfluidic arrays for high-throughput screening of 3D cell culture
This project will develop high-throughput 3D cell culture devices with perfusion by interfacing microfluidics and droplet printing technologies and subsequently applying them to model neuro-development disorders. For decades, 2D c...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
uBeat
Mimic human complexity in a Beat to revolutionize the drug d...
75K€
Cerrado
GALILEO
The first wide range flow sensor to unlock microfluidic cell...
2M€
Cerrado
PID2021-122409OB-C22
ANALISIS CUANTITATIVO DE ORGANOIDES DERIVADOS DE PACIENTES D...
145K€
Cerrado
SYNEBIO
High-throughput combinatory drugs testing on in vitro 3D cel...
150K€
Cerrado
PTQ-16-08396
Bone-on-Chip Analysis Platform for In vitro Drug Performance...
84K€
Cerrado
CPP2021-008396
SISTEMA MICROFLUIDICO PARA APLICACIONES EN TEJIDO EN UN CHIP
378K€
Cerrado
Información proyecto DropMicS
Duración del proyecto: 26 meses
Fecha Inicio: 2024-03-20
Fecha Fin: 2026-05-31
Descripción del proyecto
This project will develop high-throughput 3D cell culture devices with perfusion by interfacing microfluidics and droplet printing technologies and subsequently applying them to model neuro-development disorders. For decades, 2D cell culture followed by animal testing has been the standard for therapeutic drug discovery. 3D systems have the potential to recreate more faithful physiological conditions (cell interactions, gradients, perfusion, flow). Thus, they are expected to be more predictive for efficacy and toxicity than 2D systems and minimize the use of animals. However, there is currently no 3D model which enables high-throughput (HT) and perfusion at once: spheroids and organoids in plates can be HT but without perfusion, pressure-driven microfluidics has perfusion but is not HT, droplet microfluidics is HT but cannot handle large drug libraries and has no perfusion. Here, we will leverage the physics of wetting and capillarity to design chamber arrays with liquid-trapping geometries, which can be entirely operated by external droplet injection. We will set up designs and protocols for the embedding of cells in 3D hydrogel matrices and submit them to perfusion of medium and drug, including uniform or gradient conditions in each chamber. We will demonstrate the HT interfacing with droplet printers. Finally, we will apply the device to screen compounds and monitor the modulation of microglia (the immune cell of the brain) inflammation that affects the lives of >2 million preterm babies every year.